These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26276083)

  • 1. Toxicokinetics of lefetamine and derived diphenylethylamine designer drugs-Contribution of human cytochrome P450 isozymes to their main phase I metabolic steps.
    Wink CS; Meyer GM; Meyer MR; Maurer HH
    Toxicol Lett; 2015 Nov; 238(3):39-44. PubMed ID: 26276083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.
    Wink CS; Meyer GM; Wissenbach DK; Jacobsen-Bauer A; Meyer MR; Maurer HH
    Drug Test Anal; 2014 Oct; 6(10):1038-48. PubMed ID: 24591097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lefetamine, a controlled drug and pharmaceutical lead of new designer drugs: synthesis, metabolism, and detectability in urine and human liver preparations using GC-MS, LC-MS(n), and LC-high resolution-MS/MS.
    Wink CS; Meyer GM; Zapp J; Maurer HH
    Anal Bioanal Chem; 2015 Feb; 407(6):1545-57. PubMed ID: 25577353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytochrome P450 kinetic studies on six N-2-methoxybenzyl (NBOMe)-derived new psychoactive substances using the substrate depletion approach.
    Caspar AT; Meyer MR; Maurer HH
    Toxicol Lett; 2018 Mar; 285():1-8. PubMed ID: 29277574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs.
    Kreth K; Kovar K; Schwab M; Zanger UM
    Biochem Pharmacol; 2000 Jun; 59(12):1563-71. PubMed ID: 10799653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approach.
    Dinger J; Meyer MR; Maurer HH
    Arch Toxicol; 2016 Feb; 90(2):305-18. PubMed ID: 25417051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro identification of the cytochrome P450 isozymes involved in the N-demethylation of the active opioid metabolite nortilidine to bisnortilidine.
    Wustrow I; Riedel KD; Mikus G; Weiss J
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):633-9. PubMed ID: 22349139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human cytochrome P450 and flavin-containing monooxygenase enzymes involved in the metabolism of lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist.
    Usmani KA; Chen WG; Sadeque AJ
    Drug Metab Dispos; 2012 Apr; 40(4):761-71. PubMed ID: 22266842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
    Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
    Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
    Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
    J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cytochrome P450 enzymes involved in the metabolism of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone.
    Peters FT; Meyer MR; Theobald DS; Maurer HH
    Drug Metab Dispos; 2008 Jan; 36(1):163-8. PubMed ID: 17962373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine.
    Sauer C; Peters FT; Schwaninger AE; Meyer MR; Maurer HH
    Biochem Pharmacol; 2009 Feb; 77(3):444-50. PubMed ID: 19022226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.
    Akutsu T; Kobayashi K; Sakurada K; Ikegaya H; Furihata T; Chiba K
    Drug Metab Dispos; 2007 Jan; 35(1):72-8. PubMed ID: 17020955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethocaine, a synthetic cocaine derivative: studies on its in vitro metabolism catalyzed by P450s and NAT2.
    Meyer MR; Lindauer C; Maurer HH
    Toxicol Lett; 2014 Feb; 225(1):139-46. PubMed ID: 24309420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicokinetics of novel psychoactive substances: characterization of N-acetyltransferase (NAT) isoenzymes involved in the phase II metabolism of 2C designer drugs.
    Meyer MR; Robert A; Maurer HH
    Toxicol Lett; 2014 Jun; 227(2):124-8. PubMed ID: 24674864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
    Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).
    Meyer MR; Holderbaum A; Kavanagh P; Maurer HH
    J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
    Meyer MR; Dinger J; Schwaninger AE; Wissenbach DK; Zapp J; Fritschi G; Maurer HH
    Anal Bioanal Chem; 2012 Jan; 402(3):1249-55. PubMed ID: 22065349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
    Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes.
    Guo Z; Raeissi S; White RB; Stevens JC
    Drug Metab Dispos; 1997 Mar; 25(3):390-3. PubMed ID: 9172960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.